|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash flows from operating activities: | |||||
| Non-cash expenses including depreciation, amortization and share-based compensation | |||||
| Interest in income of equity method investments | |||||
| Net realized and unrealized investment gains | |||||
| Change in allowance for expected credit losses | |||||
| Foreign exchange and other (gains) losses | |||||
| Changes in assets – (increase) decrease: | |||||
| Reinsurance balances receivable, net | |||||
| Reinsurance recoverable on unpaid losses | |||||
| Accrued investment income | |||||
| Deferred commission and other acquisition expenses | |||||
| Funds withheld receivable | |||||
| Other assets | |||||
| Changes in liabilities – increase (decrease): | |||||
| Reserve for loss and loss adjustment expenses | |||||
| Unearned premiums | |||||
| Deferred gain on retroactive reinsurance | |||||
| Accrued expenses and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of fixed maturities | |||||
| Purchases of other investments | |||||
| Purchases of equity method investments | |||||
| Purchases of equity securities | |||||
| Proceeds from sales of fixed maturities | |||||
| Proceeds from maturities, paydowns and calls of fixed maturities | |||||
| Proceeds from sale and redemption of other investments | |||||
| Proceeds from sale and redemption of equity method investments | |||||
| Proceeds from sale and redemption of equity securities | |||||
| Net proceeds from acquisition of a subsidiary | |||||
| Others, net | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Repurchase of preference shares | |||||
| Repurchase of senior notes | |||||
| Cash settlement of restricted shares granted and options exercised | |||||
| Repurchase of common shares | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on foreign currency cash | |||||
| Net increase (decrease) in cash, restricted cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash - beginning of year | |||||
| Cash, cash equivalents and restricted cash - end of year | |||||
| Less: cash and cash equivalents held for sale, end of year | |||||
| Cash and restricted cash and equivalents, end of year, excluding held-for-sale | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest, net of amounts capitalized | |||||
| Cash paid for income taxes | |||||
| Reconciliation of cash and restricted cash reported within Consolidated Balance Sheets: | |||||
| Cash and cash equivalents, end of year | |||||
| Restricted cash and cash equivalents, end of year | |||||
Loading...